Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up.
Explore this paper's citation graph
Summary
In FIGO III and IV ovarian cancer patients, only patients with CA 125 and TPS markers below the discrimination level after three chemotherapy courses indicated a favorable prognosis.
- Type
- article
- Published
- 2009-01-01
- Cited by
- 12
- References
- 554
- Access
- Open access
- OpenAlex
- https://openalex.org/W139179242
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:24729867
Keywords
Medicine, Stage (stratigraphy), Univariate analysis, Multivariate analysis, Internal medicine
References
- Modulation of microRNA associated with ovarian cancer cells by genistein.
- Risk factors for epithelial ovarian tumours of borderline malignancy.
- Cancer screenings, diagnostic technology evolution, and cancer control.
- Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol).
- Adenoid cystic carcinoma of Bartholin's gland: a case report.
- Epidemiological overview on the effectiveness of mass screening for female cancer in Umbria, Italy.
- Sarcoma‐like ovarian nodules associated with retractile mesenteritis and retroperitoneal fibrosis
- Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells.
- Reverse staining of sodium dodecyl sulfate polyacrylamide gels by imidazole-zinc salts: sensitive detection of unmodified proteins.
- Ovarian dermoid cyst with malignant transformation and rupture of the capsule associated with chemical peritonitis: a case report and literature review.
- Expression of tubulin, p53, ki67, receptors for estrogen, and progesterone in endometrial cancer.
- Angiopoietins in tumours: the angiogenic switch
- Accuracy of intraoperative frozen section in the diagnosis of ovarian neoplasms: Experience at a tertiary oncology center
- Clinical implications of axillary sentinel lymph node 'micrometastases' in breast cancer.
- Sonographic Findings of Uterine Endometrial Stromal Sarcoma
- A DIGE-based approach to study interacting proteins.
- Umbilical metastasis of serous component as a first sign of mixed type epithelial ovarian cancer.
- Obstructive uropathy secondary to parametrial metastasis: an unusual presentation of breast carcinoma.
- Adenoid cystic carcinoma of Bartholin's gland with lung metastasis: a case report.
- Management of advanced stage uterine sarcomas: a bone of contention.
Cited by
- HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases
- The role of metabolites and metabolomics in clinically applicable biomarkers of disease
- Combined detection of sialic acid and hydroxyproline in diagnosis of ovarian cancer and its comparison with human epididymis protein 4 and carbohydrate antigen 125.
- HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer
- Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases.
- Clinical outcome of Iranian patients with advanced ovarian cancer with neoadjuvant chemotherapy versus primary debulking surgery.
- Ovarian cancer biomarkers for molecular biosensors and translational medicine
- A clinical guide to tumour markers categorized under cancer types – A review.
- Development and Characterization of Three Novel Monoclonal Antibodies Against CA-125
- Significance of blood and salivary IEX‐1 expression in diagnosis of epithelial ovarian carcinoma
- Evaluation of Serum HE4 in Ovarian Tumors, Its Comparison with Serum CA125 and Correlation with Histological Subtypes
- Liquid Biopsy and Circulating Biomarkers for the Diagnosis of Precancerous and Cancerous Oral Lesions
- Diagnostic efficiency of KISS 1 mRNA combined with CA-125 in detection of epithelial ovarian cancer
- Version for Posting to Your Own Website or Your Institution's Repository. You May Further Deposit the Accepted Author's Version on a Funder's Repository at a Funder's Request, the Role of Metabolites and Metabolomics in Clinically Applicable Biomarkers of Disease
Related papers
- Stage III and IV ovarian cancer in the South West of England: five‐year outcome analysis for cases treated in 1998
- PrognostIc Factors In Nsclc PatIents
- Prognostic factors in stage IB gastric cancer.
- Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer?
- Exploratory Analysis to Find Unfavorable Subset of Stage II Gastric Cancer for Which Surgery Alone Is the Standard Treatment; Another Target for Adjuvant Chemotherapy.
- Potential predictors of chemotherapy response in ovarian cancer--how do we define chemosensitivity?
- Clinical and emergent biomarkers and their relationship to prognosis of ovarian cancer
- Prognostic Factors in Metastatic Malignant Melanoma